South Korea Viscosupplementation Market Size & Outlook
South Korea viscosupplementation market, 2018-2030 (US$M)
Related Markets
South Korea viscosupplementation market highlights
- The South Korea viscosupplementation market generated a revenue of USD 64.0 million in 2023 and is expected to reach USD 126.6 million by 2030.
- The South Korea market is expected to grow at a CAGR of 10.2% from 2024 to 2030.
- In terms of segment, three injection was the largest revenue generating product in 2023.
- Single Injection is the most lucrative product segment registering the fastest growth during the forecast period.
Viscosupplementation market data book summary
| Market revenue in 2023 | USD 64.0 million |
| Market revenue in 2030 | USD 126.6 million |
| Growth rate | 10.2% (CAGR from 2023 to 2030) |
| Largest segment | Three injection |
| Fastest growing segment | Single Injection |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Single Injection, Three Injection, Five Injection |
| Key market players worldwide | DePuy Synthes, Sanofi SA, Smith & Nephew PLC, Anika Therapeutics Inc, Zimmer Biomet Holdings Inc, Ferring, Lifecore Biomedical Inc, LG Chem, Roche Holding AG |
Other key industry trends
- In terms of revenue, South Korea accounted for 1.3% of the global viscosupplementation market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan viscosupplementation market is projected to lead the regional market in terms of revenue in 2030.
- Australia is the fastest growing regional market in Asia Pacific and is projected to reach USD 115.5 million by 2030.
Three injection was the largest segment with a revenue share of 43.13% in 2023. Horizon Databook has segmented the South Korea viscosupplementation market based on single injection, three injection, five injection covering the revenue growth of each sub-segment from 2018 to 2030.
Osteoarthritis in South Korea is common among the elderly population with symptoms originating from different parts of the body. According to The Fifth Korean National Health and Nutrition Examination Survey, the prevalence of osteoarthritis in South Korea among the male population was 0.1%, 4.5%, and 5.6% for the hip, knee, and spine, respectively. Female groups showed the respective prevalence of 0.2%, 19%, and 16% in the hip, knee, and spine, which were significantly greater than in males.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Viscosupplementation Market Scope
Viscosupplementation Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
South Korea viscosupplementation market size, by product, 2018-2030 (US$M)
South Korea Viscosupplementation Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
